Dr Reddys Laboratories Share Price Today - Live Blog for November 26, 2025

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.11% in its share price, and it currently trades at ₹1,246.50 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a -0.14% decrease, reaching a current market price of ₹1,246.50. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.09% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,250.00 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a -0.09% dip in its share price and is currently trading at ₹1,249.00. The stock has a PE ratio of 17.9800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,249.20. The stock is currently trading at a PE of 17.9800, while the industry PE is 32.8583, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd stock remained static, maintaining its position at ₹1,249.50. The stock has a PE ratio of 17.9800, an ROE of 16.0277%, and a debt to equity ratio of 0.1625.

Demonstrating a commendable 0.16% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,249.65. In terms of valuation, the stock maintains a PE ratio of 17.9800, while the industry PE ratio stands at 32.8583.

Dr Reddys Laboratories Ltd witnessed a notable 0.13% surge in its share price and is presently trading at ₹1,246.85, captivating the attention of market participants.

Demonstrating a commendable 0.13% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,246.85. In terms of valuation, the stock maintains a PE ratio of 17.9800, while the industry PE ratio stands at 32.8583.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,245.50 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd witnessed a notable 0.06% surge in its share price and is presently trading at ₹1,245.50, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,245.50 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,245.50 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd experienced a substantial 0.06% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,245.50, making it an appealing option for investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.06%, and it is currently trading at ₹1,245.50. Additionally, the stock maintains a PE ratio of 17.9800, while the industry PE is 32.8583.

Dr Reddys Laboratories Ltd's share price has fallen by -0.04%, a situation worth noting. At present, the stock is trading at ₹1,244.80. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 17.9800, while the industry PE ratio is 32.8583.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,244.80. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.9800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a -0.04% downturn in its share price, and it's currently trading at ₹1,244.80. This situation is generating interest among value investors who are evaluating the stock's potential.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.09%, reaching the current market price of ₹1,244.85. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.09%, reaching a current market price of ₹1,243.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

After a significant 0.08% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,244.80 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd experienced a -0.06% downturn in its share price, and it's currently trading at ₹1,244.30. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd share price surged by 0.08%. With its current market price standing at ₹1,245.00 per share, this stock is garnering increased attention from the investment community.

After a -0.02% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,244.00. The stock has a PE ratio of 17.9800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

The share price of Dr Reddys Laboratories Ltd remained fixed, with no fluctuations, and is currently at ₹1,245.00. Investors may choose to investigate the factors contributing to this price stability and whether it presents an investment opportunity.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.24% gain, with the share price now at ₹1,245.15. Notably, the stock's PE ratio stands at 17.9800, and its Return on Equity (ROE) is 16.0277%.

Dr Reddys Laboratories Ltd shares saw a -0.24% decrease, reaching a current market price of ₹1,242.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 17.9800, an ROE of 16.0277% and a debt to equity ratio of 0.1625.

After a significant 0.07% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,245.55 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.01% boost, with the current market value at ₹1,244.65 per share. This surge has not gone unnoticed by investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.01%, reaching the current market price of ₹1,244.65. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd witnessed a substantial 0.01% increase in its share price and is currently trading at ₹1,244.65. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.01% upswing, and it's currently trading at ₹1,244.65 per share. Investors are closely watching this development.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.02% in its share price, and it currently trades at ₹1,244.50 per share. The stock has an ROE of 16.0277% and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.02%, reaching a current market price of ₹1,244.50. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd share price surged by 0.05%. With its current market price standing at ₹1,244.25 per share, this stock is garnering increased attention from the investment community.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.22% recently. As of now, this stock is actively trading at a current market price of ₹1,243.60 per share, attracting attention from investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.14% decline, and it currently trades at ₹1,240.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd stock price decreased by -1.37%, with the current market value at ₹1,241.75 per share. Investors are assessing the stock's potential for recovery and future growth prospects.